CVR Medical Corp V.CVM.H

Alternate Symbol(s): CRRVF

Healthcare Medical Devices

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.

TSXV:CVM.H - Post by User

CVR Medical Corp

Bullboard Posts

Post by Looneytuneson May 24, 2019 4:24am

110 Views

Post# 29770149

De Novo approval timeline

Note that a very recent De Novo approval (admittedly for a different type of devise possibly needing less data to support its application) received approval on 23rd May after having been submitted on 20th December. Following that line we could expect our approval through towards the end of June but recognising the risk (in the Crystal presentation) regarding the large amount of trial data needed to support our application, it could be later than that.

Bullboard Posts

Get a better understanding of the psychology of options trading